Merit Financial Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
32,612
+5,406
| +20% | +$60.7K | ﹤0.01% | 1238 |
|
|
2025
Q1 | $124K | Buy |
27,206
+15,146
| +126% | +$69.2K | ﹤0.01% | 1344 |
|
|
2024
Q4 | $68K | Buy |
12,060
+535
| +5% | +$3.02K | ﹤0.01% | 1138 |
|
|
2024
Q3 | $55.8K | Sell |
11,525
-307
| -3% | -$1.49K | ﹤0.01% | 814 |
|
|
2024
Q2 | $57.7K | Sell |
11,832
-215
| -2% | -$1.05K | ﹤0.01% | 902 |
|
|
2024
Q1 | $77.2K | Buy |
12,047
+22
| +0.2% | +$141 | ﹤0.01% | 844 |
|
|
2023
Q4 | $168K | Buy |
12,025
+609
| +5% | +$8.49K | 0.01% | 741 |
|
|
2023
Q3 | $151K | Buy |
+11,416
| New | +$151K | 0.01% | 703 |
|